References
- Beck A, Wurch T, Reichert JM. 6th Annual European Antibody Congress 2010: November 29–December 1, 2010, Geneva, Switzerland. mAbs 2011; 3:111 - 132
- Arnett SO, Teillaud JL, Wurch T, Reichert JM, Dunlop C, Huber M. IBC's 21st Annual Antibody Engineering and 8th Annual Antibody Therapeutics International Conferences and 2010 Annual Meeting of the Antibody Society. December 5–9, 2010, San Diego, CA USA. mAbs 2011; 3:133 - 152
- Reichert JM. Next generation and biosimilar monoclonal antibodies: essential considerations towards regulatory acceptance in Europe. February 3–4, 2011, Freiburg, Germany. mAbs 2011; 3:223 - 240
- Beck A, Senter P, Chari R. World Antibody Drug Conjugate Summit Europe: February 21–23, 2011; Frankfurt, Germany. mAbs 2011; 3:331 - 337
- Daguet A, Watier H. 2nd Charles Richet et Jules Héricourt workshop: therapeutic antibodies and anaphylaxis; May 31–June 1, 2011, Tours, France. mAbs 2011; 3:417 - 421
- Dhimolea E, Reichert JM. World Bispecific Antibody Summit, September 27–28, 2011, Boston, MA. mabs 2012; 4:4 - 16
- Lugovskoy AA, Reichert JM, Beck A. 7th Annual European Antibody Congress 2011: November 29–December 1, 2011, Geneva, Switzerland. mAbs 2012; 4 In press
- Nilvebrant J, Dunlop DC, Sircar A, Wurch T, Falkowska E, Reichert JM, et al. IBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5–8, 2011, San Diego, CA. mAbs 2012; 4 In press